Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab)
Open Access
- 9 July 2001
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (7) , 1717-1718
- https://doi.org/10.1002/1529-0131(200107)44:7<1717::aid-art299>3.0.co;2-c
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Antibodies to human myeloperoxidase in glomerular immune deposits of systemic lupus erythematosusLupus, 2000
- IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using RituximabNeurology, 1999
- IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaBlood, 1997
- Human Serum SicknessMedicine, 1988
- Anti‐Fab‘ Antibodies in Human SeraVox Sanguinis, 1977